2026-2034年全球主動式植入式醫療設備市場規模、佔有率、趨勢與成長分析報告

預計有源植入式醫療設備市場規模將從 2025 年的 308.2 億美元成長到 2034 年的 584.5 億美元，2026 年至 2034 年的複合年成長率為 7.37%。

受慢性病盛行率上升和醫療電子技術進步的推動，全球主動植入式醫療設備市場正經歷強勁成長。心臟節律器、植入式心臟整流去顫器、神經刺激設備和人工電子耳等器械廣泛應用於心臟病、神經系統疾病和聽力障礙的治療。預期壽命的延長也顯著提升了市場需求。

關鍵成長要素包括產品小型化、電池續航時間延長以及用於遠端監控的無線連接技術的進步。醫療費用支出不斷成長以及獲得先進醫療服務的途徑日益增多，進一步推動了市場擴張。人們對早期疾病診斷重要性的認知不斷提高，也促進了相關技術的普及應用。

隨著智慧植入和生物相容性材料的不斷創新，未來前景依然強勁。人工智慧（AI）和遠端患者監護技術的融合將提升設備效能。新興市場醫療基礎設施的不斷完善蘊藏著巨大的成長潛力。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球主動置入式醫療設備市場：依產品分類

• 市場分析、洞察與預測
• 心臟節律器（單心室節律器、雙心室節律器及其他）
• 植入式心臟整流去顫器（ICD）（經靜脈植入式心臟整流去顫器、皮下植入式心臟整流去顫器）
• 神經刺激設備
• 人工電子耳
• 輔助人工心臟
• 可植入式心臟監視器（植入式監測裝置）

第5章 全球主動植入式醫療設備市場：依手術類型分類

• 市場分析、洞察與預測
• 心血管植入
• 神經系統植入
• 聽覺植入
• 其他

第6章 全球主動植入式醫療設備市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院
• 門診手術中心
• 專科診所

第7章 全球主動植入式醫療設備市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Boston Scientific Corp
  • Abbott Laboratories
  • Medtronic Plc
  • Sonova Holding AG
  • LivaNova Plc
  • Biotronik SE & Co. KG
  • Cochlear Ltd
  • William Demant Holding A/S
  • Nurotron Biotechnology Co. Ltd
  • MED-EL Medical Electronics

The Active Implantable Medical Device Market size is expected to reach USD 58.45 Billion in 2034 from USD 30.82 Billion (2025) growing at a CAGR of 7.37% during 2026-2034.

The Global Active Implantable Medical Device Market has experienced robust growth due to increasing prevalence of chronic diseases and technological advancements in medical electronics. Devices such as pacemakers, implantable cardioverter defibrillators, neurostimulators, and cochlear implants are widely used to manage cardiac, neurological, and hearing disorders. Rising life expectancy has significantly boosted demand.

Major growth drivers include advancements in miniaturization, battery longevity, and wireless connectivity for remote monitoring. Increasing healthcare expenditure and improved access to advanced medical treatments further strengthen market expansion. Growing awareness of early disease diagnosis also supports adoption.

Future prospects remain strong as innovation in smart implants and bio-compatible materials continues. Integration of AI and remote patient monitoring technologies will enhance device performance. Emerging markets with expanding healthcare infrastructure will offer significant growth potential.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Cardiac Pacemaker (Single Chamber Pacemaker, Dual Chamber Pacemaker, Others)
• Implantable Cardioverter Defibrillators (Icd) (Transvenous Implantable Cardioverter Defibrillators, Subcutaneous Implantable Cardioverter Defibrillators)
• Nerve Stimulators
• Cochlear Implants
• Ventricular Assist Devices (Vad)
• Insertable Cardiac Monitor (Implantable Monitoring Devices)

By Procedure

• Cardiovascular Implants
• Neurological Implants
• Hearing Implants
• Others

By End User

• Hospitals
• Ambulatory Surgery Centers
• Specialty Clinics

COMPANIES PROFILED

• Boston Scientific Corp, Abbott Laboratories, Medtronic Plc, Sonova Holding AG, LivaNova Plc, Biotronik SE Co KG, Cochlear Ltd, William Demant Holding AS, Nurotron Biotechnology Co Ltd, MEDEL Medical Electronics

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICE MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Cardiac Pacemaker (Single Chamber Pacemaker, Dual Chamber Pacemaker, Others) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Implantable Cardioverter Defibrillators (Icd) (Transvenous Implantable Cardioverter Defibrillators, Subcutaneous Implantable Cardioverter Defibrillators) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Nerve Stimulators Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Cochlear Implants Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Ventricular Assist Devices (Vad) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Insertable Cardiac Monitor (Implantable Monitoring Devices) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICE MARKET: BY PROCEDURE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Procedure
• 5.2. Cardiovascular Implants Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Neurological Implants Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Hearing Implants Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICE MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Ambulatory Surgery Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICE MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Procedure
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Procedure
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Procedure
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Procedure
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Procedure
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICE INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Boston Scientific Corp
  • 9.2.2 Abbott Laboratories
  • 9.2.3 Medtronic Plc
  • 9.2.4 Sonova Holding AG
  • 9.2.5 LivaNova Plc
  • 9.2.6 Biotronik SE & Co. KG
  • 9.2.7 Cochlear Ltd
  • 9.2.8 William Demant Holding A/S
  • 9.2.9 Nurotron Biotechnology Co. Ltd
  • 9.2.10 MED-EL Medical Electronics